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Detection of viral nucleic acids is central to antiviral immunity.
Recently, DAI/ZBP1 (DNA-dependent activator of IRFs/Z-DNA
binding protein 1) was identified as a cytoplasmic DNA sensor
and shown to activate the interferon regulatory factor (IRF) and
nuclear factor-kappa B (NF-jB) transcription factors, leading to
type-I interferon production. DAI-induced IRF activation depends
on TANK-binding kinase 1 (TBK1), whereas signalling pathways
and molecular components involved in NF-jB activation remain
elusive. Here, we report the identification of two receptor-
interacting protein (RIP) homotypic interaction motifs (RHIMs) in
the DAI protein sequence, and show that these domains relay
DAI-induced NF-jB signals through the recruitment of the RHIM-
containing kinases RIP1 and RIP3. We show that knockdown of
not only RIP1, but also RIP3 affects DAI-induced NF-jB
activation. Importantly, RIP recruitment to DAI is inhibited by
the RHIM-containing murine cytomegalovirus (MCMV) protein
M45. These findings delineate the DAI signalling pathway
to NF-jB and suggest a possible new immune modulation strategy
of the MCMV.
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INTRODUCTION
Detection of viral nucleic acids by the host’s innate immune
system leading to the production of type I interferons (IFNs) is
a crucial event in the induction of antiviral responses and
the establishment of the so-called ‘antiviral state’ (Stetson &
Medzhitov, 2006a). Viral RNA sensors comprise endosomal Toll-
like receptors (TLR) 3, 7 and 8, as well as the cytoplasmic
helicases retinoic acid-inducible gene I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5; Meylan & Tschopp,
2006). On sensing viral RNA species, these receptors induce
downstream signalling events, resulting in the activation of
transcription factors that control IFN-b expression—namely,
interferon regulatory factor (IRF) 3 and 7, nuclear factor-kB
(NF-kB) and activator protein 1 (AP-1; Meylan & Tschopp, 2006).
DNA from viral, bacterial or even host origin can also induce
strong innate immune responses (Okabe et al, 2005; Stetson &
Medzhitov, 2006b; Muruve et al, 2008). Delivery of double-
stranded DNA in its canonical B helical form (B-DNA) into the
cytoplasm results in type-I IFN production that occurs in a TANK-
binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3)-
dependent, but TLR9-independent manner (Ishii et al, 2006;
Stetson & Medzhitov, 2006b). The IFN-inducible protein
DNA-dependent activator of IRFs (DAI), also known as DLM-1
or Z-DNA binding protein (ZBP1)) was recently identified
as the first cytosolic DNA receptor (Takaoka et al, 2007). DAI
binds to transfected B-DNA in the cytoplasm, and this induces the
recruitment of TBK1 and IRF3 to its carboxy-terminal region.
IFN responses to transfected B-DNA are potentiated by DAI
overexpression; in reverse, IRF and NF-kB activation, as well as
the subsequent induction of IFNs, are diminished by DAI
knockdown (Takaoka et al, 2007; Wang et al, 2008). Although
DAI requirements for DNA-induced type-I IFN production
vary among cell types, and data from DAI-deficient mice indicate
that additional DNA-sensing molecules must exist (Ishii et al,
2008), DAI represents the only cytoplasmic DNA receptor
identified so far for type-I IFN production and NF-kB activation.
A second DNA sensor recently discovered, absent in melanoma 2
(AIM2), seems to mediate only inflammasome activation (Burck-
stummer et al, 2009; Fernandes-Alnemri et al, 2009; Hornung
et al, 2009; Roberts et al, 2009). DAI signalling pathways remain
poorly defined (Takaoka & Taniguchi, 2008): DAI has been shown
to interact with TBK1 to mediate IRF3 activation, whereas the
mechanisms of NF-kB-pathway activation by DAI have only
recently begun to emerge (Kaiser et al, 2008).
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Here, we show that the DAI sequence contains two receptor-
interacting protein (RIP) homotypic interaction motifs (RHIMs) that
are essential for the recruitment of RIP1 and RIP3, and to mediate
NF-kB activation; both kinases contribute to DAI-induced NF-kB
activation. Furthermore, we observe that RIP3 undergoes autophos-
phorylation on binding to DAI. Interestingly, the murine cytomega-
lovirus (MCMV) RHIM-containing protein M45 blocks DAI signalling
by disrupting the RHIM-based DAI–RIP1/3 interaction, suggesting a
possible new immune modulation strategy of the MCMV.
RESULTS AND DISCUSSION
DAI/ZBP1 recruits RIP1 and RIP3 through RHIM domains
Analysis of the DAI amino-acid sequence revealed, in addition to
the two known amino-terminal Z-DNA binding domains Za and
Zb, two other conserved regions located in the central portion of
the protein (supplementary Fig S1 online). Further analysis
identified these two sequences as potential RHIMs (RHIM1 and
RHIM2; Fig 1A), which are known to mediate homotypic protein–
protein interactions. For example, a RHIM is present in the TLR-
adaptor protein TRIF, in which it is responsible for the recruitment
of the kinases RIP1 and RIP3, two other RHIM-domain-containing
proteins (Meylan et al, 2004). Interaction between RIP1 and RIP3
was also shown to take place through a homotypic RHIM–RHIM
interaction (Sun et al, 2002). In TLR3 signalling, the
RHIM-dependent TRIF–RIP1 interaction is crucial for NF-kB
activation, whereas RIP3 competes for this interaction and
thus acts as an inhibitor of TLR3-mediated NF-kB activation
(Meylan et al, 2004).
The presence of two RHIM domains in DAI suggested that,
similar to TRIF, DAI might also interact with one or both of the
RIP kinases. Indeed when co-expressed in human embryonic
kidney (HEK)293T cells, human DAI co-immunoprecipitated
with RIP1 and RIP3, but not with RIP2 and RIP4 (which lack
RHIMs), nor with Cardif (MAVS, IPS-1, VISA), the adaptor protein
essential for RIG-I/MDA5 signalling (Fig 1B; Meylan et al,
2005). Similarly, murine DAI interacted with RIP1 and RIP3
(supplementary Fig S2 online).
To map the DAI–RIP1/3 interaction site, various deletion
constructs were generated (Fig 1D). Co-immunoprecipitation
experiments showed that only the constructs of RIP1 and RIP3
that retained the RHIM domain-coding region were able to bind
co-expressed DAI (Fig 1C,E). Four residues in the RHIM domain of
RIP1 and RIP3 were previously shown to be essential for RHIM-
based interactions (Sun et al, 2002). When these crucial residues
were mutated to alanines, a total impairment of DAI recruitment
was observed (Fig 1C,F).
To investigate the involvement of the two DAI RHIM domains
in RIP1/3 recruitment, we also generated DAI constructs with
alanine substitutions in the corresponding four core residues of
their RHIMs, as well as DAI deletion constructs for the first or
second RHIM, or entire region comprising these two domains
(Fig 1G). All DAI constructs lacking a functional RHIM1 were
unable to bind to RIP1/3, whereas the targeting of the RHIM2 did
not affect this interaction when DAI and RIPs were overexpressed
(Fig 1H,I; supplementary Fig S2C,D online). Taken together, these
results show that DAI has two RHIM domains, in addition to the
two described Z-DNA binding domains, and that it recruits RIP1
and RIP3 through RHIM–RHIM homotypic interactions.
DAI-induced NF-jB activation is RHIM-dependent
Considering the crucial role of the RHIM-dependent TRIF–RIP1
association in mediating NF-kB activation on TLR3 stimu-
lation, we next examined whether this domain has a similar role
in DAI signalling.
Overexpression of human or murine DAI in HEK293T cells
activated an NF-kB-dependent promoter in a dose-dependent
manner (Fig 2A; data not shown). For this activity, the full-length
protein was required, as the N- or C-terminal deletion constructs
were inactive, regardless of the presence or absence of the RHIM
domains (supplementary Fig S3A online). In contrast to NF-kB,
neither human nor murine full-length or deletion DAI constructs
significantly activated IRF transcription factors, as monitored by an
interferon-stimulated regulatory element promoter (supplementary
Fig S3B online; data not shown) or by the upregulation of the
interferon-inducible protein RIG-I (supplementary Fig S3C online).
By contrast, Cardif or a dominant-active form of RIG-I potently
activated IRFs in the same experimental setting, and acted as
positive controls.
DAI constructs with mutations in the first or in both RHIMs
were found to be unable to induce NF-kB activation (Fig 2A).
Identical results were obtained with the corresponding deletion
constructs, supporting the essential requirement of a functional
RHIM1 domain. Furthermore, mutation or deletion of DAI RHIM2
resulted in a strong impairment of DAI activity (Fig 2A), indicating
that RHIM2 is also important for DAI function.
In accordance with these functional data, we observed that
overexpressed wild-type DAI co-immunoprecipitated with endo-
genous RIP1, and that mutation or deletion of RHIM2 strongly
affected this interaction (Fig 2B; supplementary Fig S4A online).
This is in contrast to the data with overexpressed proteins
(Fig 1H,I) and suggests that the DAI RHIM2 domain also
contributes to the recruitment of RIP1 under more physiological
conditions. As expected, DAI constructs lacking functional RHIM1
were unable to bind to endogenous RIP1 (Fig 2B; supplementary
Fig S4A online).
In addition to these observations, it was also observed that DAI
induces NF-kB activation synergistically when co-expressed with
RIP1 and RIP3 (supplementary Fig S4B,C online). This effect was
not observed on co-expression of DAI 2RHIM* mutant, which is
unable to bind to the two RIPs, nor when the RIP3 RHIM mutant
was used. It should be noted that a kinase-inactive RIP3 (K50A)
mutant did not show the synergistic NF-kB activation with DAI.
To corroborate the results of the NF-kB reporter assay, we
generated HEK293-TRex cells expressing full-length or D2RHIM
DAI in an inducible manner. In this system, induced expression of
wild-type DAI led to spontaneous I-kB phosphorylation and
degradation, whereas induction of the DAI D2RHIM protein had
no effect (Fig 2C).
These observations emphasize the ability of DAI to activate
NF-kB and further show that both RHIM domains are crucial for
this activity.
RIP1 and RIP3 mediate DAI signalling to NF-jB
The results presented above suggest that RIP1 and possibly RIP3
are essential for DAI-mediated NF-kB activation. To verify this, the
expression of RIP1 and RIP3 was knocked down using short
interfering RNA (siRNA; supplementary Fig S5A,B online).
Silencing of RIP1 with two different oligonucleotides (but not a
Activation of NF-kB by DAI
M. Rebsamen et al
&2009 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 10 | NO 8 | 2009
scientificreport
917
control siRNA) clearly impaired DAI-mediated NF-kB activation
(Fig 3A). Interestingly, downregulation of RIP3 using two different
siRNAs also resulted in a strong reduction of DAI signalling to
NF-kB (Fig 3A). Therefore, it seems that both RIP1 and RIP3
participate in mediating DAI downstream events resulting in
NF-kB activation. This situation is different from that which occurs
in TRIF signalling, the second RHIM-dependent NF-kB activating
pathway, where RIP3 acts as an inhibitor by competing with RIP1
for binding to the RHIM of TRIF (Meylan et al, 2004). In support of
the requirement of both kinases for DAI signalling, RIP1 and RIP3
can form a complex with DAI (Fig 3B).
A further indication that RIP3 is part of the DAI signalling
complex comes from the observation that co-expression of
these two proteins resulted in the appearance of a form of RIP3
that migrates more slowly on SDS–PAGE, which probably
originates from post-translational modifications (Figs 1F,3C,D).
This change was absent when the RIP3 RHIM mutant (Figs 1F,3C)
or the DAI double-RHIM mutant constructs (Fig 3D) were
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used, but was present on RIP1 and RIP3 co-expression. This
suggests that the assembly of the DAI–RIP1–RIP3 complex is
necessary to induce RIP3 modifications. To determine the nature
of the upper form of RIP3, immunoprecipitates of RIP3 were
analysed using antibodies specific for phosphorylated serine
(P-Ser), phosphorylated threonine (P-Thr) and ubiquitin. No signal
was detected for P-Ser or ubiquitin; by contrast, a strong signal
corresponding to the upper form of RIP3 was obtained using the
P-Thr antibody (Fig 3C; data not shown). The absence of a P-Thr
signal in the RIP3 RHIM-mutant immunoprecipitate argues for its
specificity. Furthermore, treatment with calf intestinal alkaline
phosphatase abolished the basal, as well as the DAI- and RIP1-
induced migratory shift of RIP3 (Fig 3D), further indicating that this
upper band is a hyper-phosphorylated form. When a kinase-
inactive RIP3 (K50A) mutant construct was used, both basal and
DAI-induced phosphorylations were abolished (Fig 3E). This
suggests that the DAI and RIP3 interaction drives RIP3 autophos-
phorylation. RIP1 does not seem to be essential for DAI-induced
RIP3 phosphorylation as this is still observed after RIP1 knock-
down (supplementary Fig S6 online). Our results raise the
interesting question of whether the lack of synergy in NF-kB
induction between the kinase-inactive RIP3 and DAI
(supplementary Fig S4C online) might be due to the absence of
DAI-induced RIP3 autophosphorylation.
Collectively, these results show that both RIP1 and RIP3
contribute to DAI-induced NF-kB activation, and that recruitment
of RIP3 to DAI induces its autophosphorylation.
The MCMV protein M45 inhibits DAI signalling
Viruses have evolved strategies to interfere with antiviral signalling
pathways. A clear example is the RIG-I/MDA5 viral RNA-sensing
pathway, which is targeted by various viruses such as hepatitis C
or influenza viruses.
In a bioinformatics search for other RHIM-containing proteins,
we found that this domain was also present in protein 45 of three
related double-stranded DNA-containing herpes viruses: MCMV
(or murid herpesvirus1), rat cytomegalovirus and tupaiid herpes-
virus 1 (supplementary Fig S7A online). Interestingly, protein 45 of
the MCMV (M45) is crucial for productive viral replication in
macrophages and endothelial cells (Brune et al, 2001), and is
essential for the MCMV spread and pathogenesis in vivo (Lembo
et al, 2004). Recently, Upton et al (2008) identified the RHIM of
MCMV M45 to be crucial for the suppression of cell death during
infection. Moreover, M45 inhibits RIP1-dependent signalling by
tumour necrosis factor (TNF; Mack et al, 2008).
These observations led us to hypothesize that M45 could target
DAI signalling. M45 is post-translationally processed at
amino acid 277 during infection (Lembo et al, 2004) and the
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RHIM-containing fragment (aa 1–277) retains RIP-binding and cell
death suppression activity (Upton et al, 2008). Therefore, we
generated a construct corresponding to this polypeptide and tested
its ability to bind to DAI, RIP1 and RIP3. As expected, interaction
with both RIP kinases was observed (Fig 4A). M451277 also
bound to DAI, which was dependent on functional DAI RHIMs
as shown by the absence of binding to the DAI RHIM double
mutant (Fig 4A).
Next we tested the effect of M451277 on DAI signalling.
Co-expression of M451277 inhibited DAI-induced NF-kB activa-
tion in a dose-dependent manner as monitored by reporter assay
(Fig 4B). This inhibitory activity was again completely dependent
on a functional RHIM, as a RHIM-mutated M451277 construct
had no effect (Fig 4B).
Reports from Upton et al (2008) and Mack et al (2008) showed
the ability of M45 to target RIP1. The first identified the
RHIM of MCMV M45 to be crucial for suppression of cell death,
whereas the second mapped the inhibitory activity of M45
in RIP1-dependent signalling by TNF to its C-terminal portion
(aa 977–1174). To clarify which of these two mechanisms account
for the effect on DAI signalling, we generated the various M45
constructs used in these studies (supplementary Fig S7B online).
According to Mack et al (2008), M45 constructs with the
C-terminal part (aa 977–1174) could reduce TNF-induced NF-kB
activation. By contrast, we found that these same constructs, when
expressed alone, induced a moderate but consistent NF-kB
activation on their own (supplementary Fig S7C online). In
support of the requirement for the RHIM, but not the C-terminal
domain of M45 to inhibit DAI signalling, we observed that an
M45 construct comprising amino acids 1–976 blocked the
DAI-induced NF-kB activation, and that this effect was abrogated
by mutating the RHIM domain (Fig 4B).
Considering that M451277 interacts with the DAI RHIM
domain, we hypothesized that this could affect the recruitment
of RIP1 and RIP3. Indeed, binding of RIP1 and/or RIP3 to DAI was
strongly affected by the co-expression of RHIM-containing M45
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constructs (Fig 4C,D; data not shown). By contrast, the interaction
between DAI and RIP kinases was altered neither by the
expression of RHIM-mutated M45 constructs nor by the M45
C-terminal cleavage fragment. Interestingly, RIP3 phosphorylation
was inhibited by M45 in an identical RHIM-dependent manner
(Fig 4D). Thus, the MCMV M45 protein has the potential to block
DAI signalling to NF-kB by interfering with the RHIM-dependent
recruitment of RIP1 and RIP3. In line with this, one might consider
the idea that M45 could also interfere with the DAI–RIPs
complex by targeting not only DAI RHIMs but also RIP1 and
RIP3 RHIM domains.
In summary, we have identified DAI as a new RHIM-containing
protein, and provide evidence that these domains are crucial for
the recruitment of RIP1 and RIP3, and subsequent NF-kB
activation, which is in agreement with the recent report from
Kaiser et al (2008). Furthermore, the MCMV M45 protein has the
potential to block this pathway by disrupting DAI–RIP inter-
actions. This, together with the observation by Upton et al (2008)
that M45 is crucial for the suppression of cell death during MCMV
infection, makes it highly probable that inhibition of DAI
signalling contributes to the requirement of M45 for MCMV
replication and pathogenesis in vivo.
METHODS
Expression vectors. Full-length human and murine DAI comple-
mentary DNAs were amplified from expressed sequence-tag (EST)
clones (human DAI, IMAGE: 40121532 (imaGenes GmbH, Berlin,
Germany); murine DAI, MMM1013-65907 (Open Biosystems,
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Fig 4 | The RHIM-containing protein M45 of the MCMV inhibits DAI signalling. (A) HEK293T cells were transfected with VSV–M451277 or an empty
vector and the indicated Flag constructs. IP and XT were analysed by IB. (B) HEK239T were transfected with an NF-kB reporter plasmid together with
an empty plasmid (e.v) or DAI in combination with increasing doses of the indicated M45 constructs (shown in supplementary Fig S6B online) and
were analysed for NF-kB-dependent luciferase activity 24 h later. Data are the mean values±s.d. of three transfection points from one experiment;
results are representative of two independent experiments. (C,D) HEK293T cells were transfected with the indicated VSV or Flag constructs. IP and
XT were analysed by IB. In (D), white and black arrowheads indicate modified and unmodified RIP3, respectively. The asterisks indicate constructs
with alanine substitutions of the four amino acids (highlighted in supplementary Fig S6A online). DAI, DNA-dependent activator of IRFs; FL, full
length; HEK, human embryonic kidney; IB, immunoblot; IP, immunoprecipitates; MCMV, murine cytomegalovirus; NF-kB, nuclear factor-kappa B;
RHIM, RIP homotypic interaction motifs; RIP, receptor-interacting protein; XT, cell extracts; VSV, vesicular stomatitis virus.
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Huntsville, AL, USA) by standard PCR with Pwo Superyield
polymerase (Roche Diagnostics GmbH, Mannheim, Germany).
A mutation present in the RHIM domain of mouse EST (R197G)
was reverted by double PCR. M45 sequence encoding amino
acids 1–277 was amplified by standard PCR from total purified
MCMV genomic DNA. M45 sequence encoding amino acids
278–1174 was obtained from Genscript Corporation (Piscataway,
NJ, USA). Full-length M45 DNA was obtained from this construct
by double PCR. DAI/RIP1/RIP3/M45 deletion- and RHIM/kinase
domain-mutant constructs were amplified by standard and double
PCR, respectively.
In RHIM mutant constructs, alanine substitution targeted
the following amino acids: RIP1 (539–542), RIP3 (458–461),
DAI (RHIM1: 206–209, RHIM2: 264–267) and M45 (61–64). The
fidelity of the PCR amplifications was confirmed by sequencing.
PCR products were cloned into a derivative of pCR3
(Invitrogen, Carlsbad, CA, USA), in frame with an N-terminal or
C-terminal tag, VSV (vesicular stomatitis virus) or Flag.
RIP1, RIP3, RIP2, RIP4, Cardif, RIG-I 2CARD and interferon-
stimulated regulatory element reporter constructs were generated
as described previously (Meylan et al, 2004; Michallet et al, 2008;
Rebsamen et al, 2008).
NF-kB luciferase reporter construct (provided by V. Jongeneel)
was derived from kB/thymidinekinase 5 chloramphenicol acetyl-
transferase construct (Shakhov et al, 1990): the 5-kB site sequence
was cloned into pGL2-Basic vector (E1641, Promega, Madison,
WI, USA).
Phosphatase assay. 24h after transfection, HEK293T cells were
lysed in NP40 lysis buffer (50mM Tris pH 7.8, 150mM NaCl, 1%
Nonidet P-40, complete protease inhibitor cocktail (Roche)) at
4 1C. After a centrifugation step (for 10min, 13,000 r.p.m. at 4 1C),
supernatant was collected, New England Biolabs (NEB, Ipswich,
MA, USA) buffer-3 added and incubated for 10min at 37 1C with
or without 10 units per 30 ml of calf intestinal alkaline phosphatase
CIP (NEB).
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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